Description
HLA B27 Disease Associates
Sample Type: Whole Blood
Tests Included:
HLA-B27 typing
Sample Required:
Blood sample
Test Time:
Results typically available within a few days.
What is the test?
This test identifies the presence of the HLA-B27 gene associated with certain autoimmune diseases, particularly ankylosing spondylitis and related conditions.
Test Procedure:
A blood sample is collected and analyzed to identify the presence of the HLA-B27 gene.
When to take the test:
For individuals with suspected autoimmune diseases or certain inflammatory conditions.
Who should take the test:
Individuals with symptoms or family history of conditions associated with HLA-B27.
Precautions for exceptional cases:
Notify the healthcare provider about any pertinent medical history or ongoing treatments.
Frequently Asked Questions (FAQs) for HLA B27 Disease Associates:
Q1: Can a positive HLA-B27 result confirm a specific disease?
A: No, it indicates a higher risk for certain autoimmune conditions but doesn’t confirm the disease itself.
Q2: What conditions are associated with HLA-B27?
A: Ankylosing spondylitis, reactive arthritis, and other spondyloarthropathies are commonly associated.
Q3: Is a negative HLA-B27 result conclusive for ruling out these diseases?
A: No, as some individuals with these conditions might not have the HLA-B27 gene.
Q4: Can HLA-B27 testing predict the severity of ankylosing spondylitis?
A: HLA-B27 positivity might be linked to more severe disease in some cases, but it doesn’t predict disease progression in all individuals.
Q5: Can medications or health conditions affect HLA-B27 test results?
A: No, medications or existing health conditions typically do not affect HLA-B27 test outcomes.
*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.
